arrow
K

Karen H. Miga

University of California Santa Cruz
H指数:34
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Haplotype-resolved DiMeLo-seq maps centromeric chromatin in a complete diploid human genome

单体型解析的DiMeLo-seq技术绘制完整二倍体人类基因组着丝粒染色质图谱

2026-08-120
PRE
Neocentromeres fail to maintain DNA methylation boundaries, driving CENP-A drift, instability, and chromosome missegregation

新着丝粒无法维持DNA甲基化边界,导致CENP-A漂移、不稳定性和染色体错分离

2026-08-010
PRE
Accurate somatic small variant discovery for multiple sequencing technologies with DeepSomatic

使用deepsmatoma实现多种测序技术的准确体细胞小变异发现

2025-10-160
PRE
Chromosome-specific epigenetic control and transmission of ribosomal DNA arrays in Hominidae genomes

人科基因组中核糖体DNA数组的染色体特异性表观遗传调控与传递

2025-10-020
OAAI
DNA methylation influences human centromere positioning and function

DNA甲基化影响人类着丝粒定位和功能

2025-09-040
OAAI
Correction: Development and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair

更正:开发和广泛测序一个得到广泛认可的“Genome in a Bottle”匹配的肿瘤-正常配对样本

2025-08-080
OAAI
Development and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair

开发并广泛测序一种在Genome in a Bottle框架下获得广泛共识的匹配肿瘤-正常样本对

2025-07-160
OAAI
Severus detects somatic structural variation and complex rearrangements in cancer genomes using long-read sequencing

Severus通过长读长测序检测癌症基因组中的体细胞结构变异和复杂重排

2025-04-041
PRE
Integrated analysis of the complete sequence of a macaque genome

恒河猴基因组完整序列的整合分析

NATURE
IF48.5
2025-02-261
PRE
The Ruminant Telomere-to-Telomere (RT2T) Consortium

反刍动物端粒到端粒(RT2T)联盟

2024-08-051
PRE
The complete sequence and comparative analysis of ape sex chromosomes

猿类性染色体的全序列及比较分析

Nature
IF48.5
2024-05-290
OAAI
Phased nanopore assembly with Shasta and modular graph phasing with GFAse

用Shasta进行的分相纳米孔组装和用GFAse进行的模块化图形分相

2024-04-163
OA
Scalable Nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylation
2023-09-1428
OA
The complete sequence of a human Y chromosome

人类Y染色体的完整序列

Nature
IF48.5
2023-08-230
PRE